219 related articles for article (PubMed ID: 2531219)
21. [Quantification of renal function with 99mTc-MAG3--quantification of tubular extraction rate using Bubeck's method].
Yamazaki T; Maruoka S; Sakamoto K
Kaku Igaku; 1995 Nov; 32(11):1199-206. PubMed ID: 8558788
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive measurement of renal function with 99mTc-MAG3 gamma-camera renography based on the one-compartment model.
Oriuchi N; Onishi Y; Kitamura H; Inoue T; Tomaru Y; Higuchi T; Inoue T; Endo K
Clin Nephrol; 1998 Nov; 50(5):289-94. PubMed ID: 9840316
[TBL] [Abstract][Full Text] [Related]
23. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
[TBL] [Abstract][Full Text] [Related]
24. 99Tcm-MAG3 for quantitation of differential renal function.
Llamas-Elvira JM; Martinez-Paredes M; Jimenez-Heffernan A; Sopena R; Requena MJ; Gonzalez FM; Torres M; Mateo A
Nucl Med Commun; 1989 Oct; 10(10):759-64. PubMed ID: 2559380
[TBL] [Abstract][Full Text] [Related]
25. Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique.
Prenen JA; de Klerk JM; van het Schip AD; van Rijk PP
J Nucl Med; 1991 Nov; 32(11):2057-60. PubMed ID: 1834812
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Tc-99m MAG3 and Tc-99m DTPA in renal transplant patients with impaired renal function.
Taylor A; Ziffer JA; Eshima D
Clin Nucl Med; 1990 Jun; 15(6):371-8. PubMed ID: 2141307
[TBL] [Abstract][Full Text] [Related]
27. Effect of the NSAID diclofenac on 99mTc-MAG3 and 99mTc-DTPA renography.
Mustafa S; Elgazzar AH
J Nucl Med; 2013 May; 54(5):801-6. PubMed ID: 23528384
[TBL] [Abstract][Full Text] [Related]
28. A comparative study of renal scintigraphy and clearance with technetium-99m-MAG3 and iodine-123-hippurate in patients with renal disorders.
Müller-Suur R; Bois-Svensson I; Mesko L
J Nucl Med; 1990 Nov; 31(11):1811-7. PubMed ID: 2146371
[TBL] [Abstract][Full Text] [Related]
29. Phase II study of Tc-99m MAG3 in patients with nephrourologic diseases.
Itoh K; Tsukamoto E; Kakizaki H; Nonomura K; Koyanagi T; Furudate M; Torizuka K
Clin Nucl Med; 1993 May; 18(5):387-93. PubMed ID: 8508572
[TBL] [Abstract][Full Text] [Related]
30. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.
Taylor A; Eshima D; Fritzberg AR; Christian PE; Kasina S
J Nucl Med; 1986 Jun; 27(6):795-803. PubMed ID: 2940350
[TBL] [Abstract][Full Text] [Related]
31. Technetium-99m-MAG3 clearance as a parameter of effective renal plasma flow in patients with proteinuria and lowered serum albumin levels.
Kengen RA; Meijer S; Beekhuis H; Piers DA
J Nucl Med; 1991 Sep; 32(9):1709-12. PubMed ID: 1831839
[TBL] [Abstract][Full Text] [Related]
32. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
Coveney JR; Robbins MS
J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
[TBL] [Abstract][Full Text] [Related]
33. Estimation of technetium 99m mercaptoacetyltriglycine plasma clearance by use of one single plasma sample.
Müller-Suur R; Magnusson G; Bois-Svensson I; Jansson B
Eur J Nucl Med; 1991; 18(1):28-31. PubMed ID: 1826882
[TBL] [Abstract][Full Text] [Related]
34. Technetium 99m mercaptoacetyltriglycine gamma camera clearance calculations: methodological problems.
Tondeur M; Piepsz A; Dobbeleir A; Ham H
Eur J Nucl Med; 1991; 18(2):83-6. PubMed ID: 1828421
[TBL] [Abstract][Full Text] [Related]
35. Comparison of 99Tcm-mercaptoacetyltriglycine and 131I-orthoiodohippurate in determination of effective renal plasma flow (ERPF).
Abdel-Dayem HM; Sadek S; al-Bahar R; Sabha M; el-Sayed M
Nucl Med Commun; 1989 Feb; 10(2):99-107. PubMed ID: 2525236
[TBL] [Abstract][Full Text] [Related]
36. Technetium-99m MAG3 kit formulation: preliminary results in normal volunteers and patients with renal failure.
Taylor A; Eshima D; Christian PE; Wooten WW; Hansen L; McElvany K
J Nucl Med; 1988 May; 29(5):616-22. PubMed ID: 2967353
[TBL] [Abstract][Full Text] [Related]
37. Technetium-99m-L,L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals.
Verbruggen AM; Nosco DL; Van Nerom CG; Bormans GM; Adriaens PJ; De Roo MJ
J Nucl Med; 1992 Apr; 33(4):551-7. PubMed ID: 1532419
[TBL] [Abstract][Full Text] [Related]
38. [The estimation of effective renal plasma flow (ERPF) based on two compartment analysis using 99mTc-mercaptoacetyltriglycine (99mTc-MAG3)].
Ha-Kawa SK; Suga Y; Satou H; Tanaka Y
Kaku Igaku; 1994 Feb; 31(2):175-81. PubMed ID: 8121073
[TBL] [Abstract][Full Text] [Related]
39. Determination of extrarenal plasma clearance and hepatic uptake of technetium-99m-mercaptoacetyltriglycine in cats.
Drost WT; McLoughlin MA; Mattoon JS; Lerche P; Samii VF; DiBartola SP; Chew DJ; Barthez PY
Am J Vet Res; 2003 Sep; 64(9):1076-80. PubMed ID: 13677382
[TBL] [Abstract][Full Text] [Related]
40. [A comparison of different methods of calculating clearances using 99mTc-mercaptoacetyltriglycine and 123I- or 131I-ortho-iodohippuric acid].
Keske U; Cordes M; Hosten N; Roll D; Hunger J; Felix R
Nuklearmedizin; 1990 Jun; 29(3):93-100. PubMed ID: 2144045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
